acute Outcomes of Cigarette Smoke and Electronic Cigarette aerosol Inhalation in a Murine Model.
Nonclinical
Respiratory Toxicity
In Vitro
da Silva (2022)
Exposure assessment of Ultrafine Particles and hazardous Chemicals in Electronic Cigarettes.
Nonclinical
Chemical
Analysis
Dada (2019)
Evidence for the coupling of refill liquids content and new particle formation in electronic cigarette vapors.
Nonclinical
Chemical
Analysis
Dada (2022)
Smoking Cessation and Improvement in Mental Health Outcomes: Do People Who Quit Smoking by Switching to Electronic Cigarettes Experience Improvement in Mental Health?
Population Clinical
Cessation
Tobacco
Dahal (2020)
Exposure to Secondhand Aerosol From Electronic Cigarettes Among US Youth From 2015 to 2018.
Population Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Dai (2020)
Prevalence and Factors Associated With Youth Vaping Cessation Intention and Quit Attempts.
Population Clinical
Cessation
ENDS
Dai (2021)
a Longitudinal Study of Exposure to Tobacco-Related Toxicants and Subsequent Respiratory Symptoms among U.S. adults with Varying E-cigarette Use Status.
Individual Clinical
Respiratory Toxicity; Biomarkers
Relative Health Effects Of User; Biomarkers Of Exposure
Dai (2020)
Association of electronic cigarette vaping and subsequent smoking relapse among former smokers.
Population Clinical
Likelihood Of Use
Former Smokers Switching From ENDS To Tobacco
Dai (2019)
Prevalence of e-Cigarette Use Among Adults in the United States, 2014-2018.
Population Clinical
Consumer Use
Youth Use & Appeal
Dai (2019)
Changes in electronic cigarette use among U.S. Adults by cigarette smoking status, socciodemographics, and subjective depression, 2019-2020.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Dai (2022)